Company: SUPN
Filing Date: 2025-06-16
Form Type: 8-K
Source: 0001104659-25-059687
Chunk: 5

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-06-16
Form: 8-K
Item: Item 1.01
Chunk 5
---
ies to the Merger Agreement instead of establishing these matters as facts. Accordingly, investors should consider the information
in the Merger Agreement in conjunction with the entirety of the factual disclosure about the Company and Sage in the Company’s and
Sage’s respective public reports filed with the Securities and Exchange Commission (the “ SEC”). Information concerning
the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information
may or may not be fully reflected in the Company’s or Sage’s public disclosures.